NCT05108805 2025-03-27Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient SettingVanderbilt-Ingram Cancer CenterPhase 4 Completed25 enrolled 17 charts
NCT01990534 2021-04-09A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin LymphomaTakedaPhase 4 Completed60 enrolled 21 charts
NCT00003398 2019-10-17Bone Marrow Transplantation in Treating Patients With Hematologic CancerUniversity of Maryland, BaltimorePhase 4 Completed45 enrolled
NCT03376958 2019-07-25Apatinib for Relapsed and Refractory Diffuse Large B Cell LymphomaZhengzhou UniversityPhase 4 Completed32 enrolled